Loading
Latest filing published 18 Nov 2013 for ROCHESTER MEDICAL CORPORATION.
No signal scores available.
James M. Carper discloses dealings in Rochester Medical Corporation to SEC (Form 4). We count 2 filings, every one of them for a trade on 14 November 2013.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 18 November 2013, the filings show a share grant in Rochester Medical Corporation. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations